The revolutionary preparation from obesity] plans to let out AstraZeneca </"0"

Show original
The Anglo-Swedish pharmacological company AstraZeneca plc, earned billion dollars on a vaccine against Koronavirus during a pandemic, promised to let out a new preparation from obesity and diabetes of the II type. About it reports broadcasting company "CNBC". For this purpose the pharmacological giant signed contract with the Chinese company Eccogene specializing on development of drugs, capable to fight against metabolism violation. After information on the multi-billion transaction got to mass media, actions of AstraZeneca plc sharply went up in price. "Considering the development loudspeaker companies in the current year, we raised our annual forecast...
Analysis
×
Pascal Klod Rolan Sorio
Last position: CEO (AstraZeneca plc)
Mikhail Murashko
Last position: Minister (Ministry of Health of the Russian Federation)
263
AstraZeneca plc
Main activity:Health care and social services
29